Loading viewer...
conference
Format: PDF conference
Regeneron Pharmaceuticals presented its strategy and business update at the J.P. Morgan Healthcare Conference in January 2023, featuring insights from CEO Leonard S. Schleifer. The presentation covered the company's pipeline including EYLEA, Dupixent, Libtayo, and other product candidates, along with forward-looking clinical and commercial developments.
investor_presentation
23 Pages
conference
36 Pages
Unknown
Magellan Midstream Partners 2017 Investor Conference Presentation
conferenceconference
18 Pages
Magellan Midstream Partners
Lifezone Metals 2023 Precious Metals Summit Presentation
conferenceconference
16 Pages
Lifezone Metals Limited